Pneumatosis cystoides intestinalis (PCI) is still a poorly understood phenomenon, currently considered to result from primary mucosal insult from varying causes. We report a case of severe PCI in a patient with chronic GVHD after bone marrow transplantation ( 
mer chemotherapy, underlying malignancy, radiotherapy, inflammatory bowel disease or persistent GVHD with subsequent long-term steroid treatment have been reported as being associated with PCI. [4] [5] [6] [7] In addition to various mechanistic theories involving increased intraluminal pressure as the driving force in PCI, pulmonary 8 and infectious 9 diseases have also been proposed to explain the abnormal appearance of gas within the intestinal wall. Treatment approaches reflect the lack of precise knowledge regarding the underlying pathophysiology, and range from hyperbaric oxygen therapy 10 to broad-spectrum antibiotics, 11 or even surgical resection. 12 In the majority of cases, secondary PCI represents a radiological finding without pronounced symptoms, thus allowing a conservative approach to treatment. Surgery is reserved either for cases of suspected bowel obstruction or ischemia, or in cases of abdominal discomfort of unclear aetiology in patients with multiorgan problems.
The following case report illustrates the complex nature of diagnostic and therapeutical procedures in secondary PCI.
Case report
A 46-year-old patient underwent surgical treatment in July 1996 for extensive cancer of the left breast with synchronous dissection of the contralateral axilla (6/23) and excision biopsy of the right breast. Histological examination revealed the tumour to be stage pT4b, pN2 (39/39), M1, G3. The biopsy of the right breast itself was unremarkable; however, 6/23 lymph nodes in the right axilla proved to be positive. Chemotherapy was originally given according to the EC-scheme (four cycles), followed by high-dose chemotherapy (carboplatin, cyclophosphamide and PBSCT) in November 1996 and further high-dose chemotherapy (mitoxantrone, thiotepa and PBSCT) in January 1997. Radiotherapy was given to both axillae and the left breast region. Increasing bone marrow failure led to repeated admissions for blood cell transfusions over the following months. Long-term chemotherapy was performed with zoladex. In December 1998, secondary AML (FAB subtype F4) was diagnosed and subsequently treated by polychemotherapy according to the DAV scheme in December 1998, and the HAM scheme in January 1999.
Complete marrow remission was achieved. Prior to the planned BMT, a right-sided mastectomy was performed in March 1999 due to a suspicious finding on PET. Histology revealed no signs of malignancy.
Allogeneic BMT took place in May 1999 (HLA-identical sister), following risk-adapted conditioning with TBI (8 Gy), fludarabine 3 × 50 mg and cyclophosphamide 2 × 3.6 g. Intravenous cyclosporin A had been started 1 day prior to BMT, with further oral administration of 100 mg twice daily and additional doses of methotrexate given on day 1 post BMT (25 mg) and day 6 (9 mg). Long-term immunosuppression was maintained with low-dose steroids and mycophenolate mofetil (blood levels ca. 5 g/ml).
Shortly after BMT, the patient developed acute, biopsyproven GVHD of the skin, preceded by severe diarrhoea, both which responded to steroid treatment (initial dose 3 × 50 mg/day Decortin H). Colonoscopy was not performed, as the frequency and severity of the assumed GVHDrelated diarrhoea declined within 12 days from the onset.
Routine follow-ups demonstrated no signs of relapse. However, the patient suffered from repeated episodes of gastrointestinal disturbance leading to a gradual weight loss of 10 kg. Pulmonary CMV infection was detected via bronchoalveolar lavage in November 1999 and treated with ganciclovir, with no microbiological signs of CMV enteritis at any time. Epigastric discomfort led to a further gastroscopy in December 1999, which revealed a retrogastric depression from a newly developed mass in the head of the pancreas. A simultaneous increase in the tumour marker CA 125 (173.8 U/ml, normal range Ͻ34 U/ml) necessitated further diagnostic procedures, especially with respect to a possible ovarian malignancy, which could not be confirmed radiologically. As interventional biopsy was regarded as unfeasible, surgical exploration was performed in February 2000. This revealed pancreatitis without signs of pancreatic malignancy on transduodenal and open biopsy. The abdomen was completely examined, excluding any further pathology. Histological examination of the pancreas biopsies revealed focal lymphoplasmacytoid infiltration. In the light of the patient's history, this finding was felt to be associated with persistent chronic GVHD, as the skin involvement had increased in parallel, necessitating renewed steroid therapy. Although the patient recovered rapidly from the abdominal surgery, she then began to complain of lower abdominal pain in March 2000. An acute exacerbation led to a further admission when she was found to be in poor general condition with a distended, tense abdomen lacking normal bowel movements.
Medication at the time consisted of standard doses of aciclovir, fluconazole, ciprofloxacin, pantoprazole, mycophenolatemofetil 1 × 500 mg, prednisolone 15 mg.
The relevant laboratory values at admission were: leukocytes: 4.08 × 10 9 /l, CRP 11.1 mg/l, thrombocytes 56 × 10 9 /l, haemoglobin 12.9 g/dl, MMF level 5.0 g/ml, CA 125 473.6 U/ml.
A plain abdominal X-ray ( Figure 1 ) demonstrated massive pericolic gas accumulation around the ascending and transverse colon, with no signs of gastrointestinal perforation. Taking the patient's history into account -laparotomy with transduodenal biopsy 7 weeks before, longterm steroid medication for chronic GVHD -a CT scan was performed, which supported the diagnosis of a locally contained perforation of the colon with pneumatosis coli. Laparotomy revealed no signs of gastrointestinal perforation, although amber-coloured ascites were present in the pelvis.The major finding was an extreme form of pneumatosis cystoides intestinalis, mainly of the right and transverse colon and attached mesentery (Figure 2) , in an otherwise undistended colon lacking signs of transmural ischemia. The small intestine and left colon and sigmoid were uninvolved. PCI was entirely restricted to the right colon with a clear-cut 'demarcation line' at the ileo-cecal junction, involving both the intestinal wall and mesentry. During the 1-h surgical procedure a decline in the PCI was seen and the abdomen was closed following sampling of the ascites, which contained only inflammatory cells.
The post-operative course was uneventful, additional treatment consisting of broad-spectrum antibiotic therapy for 5 days, a moderate increase in steroid treatment to a maximum of 0.5 mg/kg and supplemental oxygen via a face mask. The patient was discharged on the post-operative day 9 in good general condition with no further gastrointestinal problems.
Regular follow-up visits until February 2001 revealed no clinical or radiological signs of PCI recurrence despite ongoing chronic GVHD. 
Discussion
Although more than a century has passed since the original description by Bang 12 of PCI in a human setting the underlying pathophysiology remains unclear. As PCI may represent a common endproduct of many underlying causes, it is quite possible that various theories proposed in the past may each contribute to the explanation of this phenomenon.
Circumscribed PCI has been reported by Knechtle et al 13 in connection with a localised intestinal pathology such as infarction or obstruction, and is associated with an extremely high rate of mortality despite surgical resection. However, gross PCI in the same series responded well to conservative treatment in the majority of cases, possibly reflecting a different etiology. Obvious alterations in mucosal architecture were described by Pieterse 14 in a series of colon resections and biopsies for underlying PCI, representing as such a negatively selected group of patients. Histomorphological changes were similar to those observed in inflammatory bowel disease; predominantly cryptitis, crypt abscesses and dilation, partial crypt rupture and granuloma formation. These observations offered strong support to the theory that subserosal gas formation developed as a result of primary mucosal injury from various causes.
Among the main entities presently known to lead to mucosal damage -apart from iatrogenic sources such as endoscopy, surgical placement of a feeding jejunostomy tube or mere gastrointestinal anastomosis -are inflammatory bowel disease, radiation enteritis, chronic GVHD, mixed connective tissue disease, systemic chemotherapy and various immunodeficiency states with concomitant infectious complications. [4] [5] [6] [7] 15 PCI has been described as occurring 2-3 months following allogeneic stem cell transplantation in patients requiring chronic steroid treatment for GVHD. 16 Passage of intraluminal gas into the submucosa requires in addition damaged muscularis mucosae, which may occur during the course of an inflammatory process or in conjuncBone Marrow Transplantation tion with an anatomic defect such as alteration of lymphoid follicles by steroid-induced lymphocyte depletion. [17] [18] [19] Further spread of gas may occur either in a linear or a cystic pattern, leading to distinct radiologic findings. In nonimmunocompromised patients linear gas distribution has been regarded as a significant clinical indication of impending intestinal perforation due to epithelial necrosis. 13 Recent reports concerning immunocompromised patients do not support these findings, however, since a large proportion of patients have linear gas distribution in the colonic wall without subsequent serious complications. 7, 20, 21 Similarly, the right colon, which according to surgical experience seems to be more susceptible to ischemia than the rest of the colon, is predominantly affected by PCI in such patients. 6 Gastrointestinal GVHD, which occurs infrequently in patients suffering from chronic GVHD following successful BMT or PBSCT, [22] [23] [24] [25] may lead to substantial mucosal damage, eventually resulting in diarrhoea, abdominal pain or pseudo-obstruction with increases of intestinal pressure up to 90 mm Hg, either alone or in combination with an additional superinfection, eg CMV. 4, 26 The spectrum of treatment modalities ranges from emergency surgery and resection, to spontaneous resolution with conservative treatment, which is the approach in the majority of patients.
Reports of spontaneous recovery from PCI 6,27,28 may lead to difficulties in the interpretation of efficacy of various treatment approaches taken. Antibiotic treatment has been reported to have led to resolution of PCI, 29 supporting the theory of bacterial involvement. Similarly, oxygen therapy with partial pressures as high as 350 mm Hg has been successfully used in symptomatic PCI as severe as PCIinduced colonic obstruction. 30, 31 In addition to the possible deleterious effect on anaerobe bacterial overgrowth resulting in reduced gas production, an increased partial pressure of oxygen in the surrounding blood stream may lead to enhanced resorption of gas pockets, which predominantly contain nitrogen and carbon monoxide. Bowel rest and special diet formulas have also been advocated as further supportive measures in PCI. 32, 33 In general, surgical exploration and colonic resection should be reserved for patients with clinical symptoms such as worsening peritoneal signs, severe lactic acidosis, signs of intestinal obstruction or rectal bleeding, 3, 13, 28, 34, 35 irrespective of radiological appearance. The indications for surgical exploration may be extended in high-risk categories of patients such as those receiving continuous immunosuppression, where undetected intestinal pathology may have deleterious results.
In this case, a severe form of PCI developed shortly after surgery for a suspected pancreatic malignancy following earlier primary breast cancer and subsequent polychemotherapy. Acute intestinal GVHD responded well to steroid therapy, although further abdominal discomfort was reported some months later, eventually leading to surgical exploration. Histological findings and laboratory data led to the assumption of a rare case of pancreatic involvement in the by now chronic GVHD, which had simultaneously been detected by skin biopsy. As a result of these findings, steroid therapy was renewed shortly before PCI was detected, due to a rapid deterioration in the patient's general condition in conjunction with distinct abdominal tenderness. The patient's specific history (previous surgery with transduodenal biopsy, chronic steroid and immunosuppressive therapy) and rapid decline of general condition supported the unusual indication for emergency surgery in PCI in the expectation of intestinal perforation.
